These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7534075)
21. Insulin suppresses the increased activities of lysosomal cathepsins and ubiquitin conjugation system in burn-injured rats. Solomon V; Madihally S; Yarmush M; Toner M J Surg Res; 2000 Sep; 93(1):120-6. PubMed ID: 10945952 [TBL] [Abstract][Full Text] [Related]
22. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor. Lorenzo K; Ton P; Clark JL; Coulibaly S; Mach L Cancer Res; 2000 Aug; 60(15):4070-6. PubMed ID: 10945612 [TBL] [Abstract][Full Text] [Related]
23. E-64 [L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane] and related epoxides as inhibitors of cysteine proteinases. Barrett AJ; Kembhavi AA; Hanada K Acta Biol Med Ger; 1981; 40(10-11):1513-7. PubMed ID: 7044005 [TBL] [Abstract][Full Text] [Related]
24. Glucose regulates protein catabolism in ras-transformed fibroblasts through a lysosomal-dependent proteolytic pathway. Tournu C; Obled A; Roux MP; Ferrara M; Omura S; Béchet DM Biochem J; 2001 Jul; 357(Pt 1):255-61. PubMed ID: 11415457 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms and regulation of lysosomal proteolysis. Katunuma N Revis Biol Celular; 1989; 20():35-61. PubMed ID: 2700097 [TBL] [Abstract][Full Text] [Related]
26. Inhibitions of cathepsin B and cathepsin L by E-64 in vivo. II. Incorporation of [3H]E-64 into rat liver lysosomes in vivo. Hashida S; Kominami E; Katunuma N J Biochem; 1982 Apr; 91(4):1373-80. PubMed ID: 7096292 [TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical study of cathepsin L and rat salivary cystatin-3 in rat osteoclasts treated with E-64 in vivo. Moroi R; Yamaza T; Nishiura T; Nishimura Y; Terada Y; Abe K; Himeno M; Tanaka T Arch Oral Biol; 1997 Apr; 42(4):305-15. PubMed ID: 9222450 [TBL] [Abstract][Full Text] [Related]
28. Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels. Navab R; Pedraza C; Fallavollita L; Wang N; Chevet E; Auguste P; Jenna S; You Z; Bikfalvi A; Hu J; O'Connor R; Erickson A; Mort JS; Brodt P Oncogene; 2008 Aug; 27(37):4973-85. PubMed ID: 18469859 [TBL] [Abstract][Full Text] [Related]
29. Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo. Hashida S; Towatari T; Kominami E; Katunuma N J Biochem; 1980 Dec; 88(6):1805-11. PubMed ID: 7462205 [TBL] [Abstract][Full Text] [Related]
30. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases. Premzl A; Puizdar V; Zavasnik-Bergant V; Kopitar-Jerala N; Lah TT; Katunuma N; Sloane BF; Turk V; Kos J Biol Chem; 2001 May; 382(5):853-7. PubMed ID: 11517941 [TBL] [Abstract][Full Text] [Related]
31. Detection of lysosomal cysteine proteinases in microglia: flow cytometric measurement and histochemical localization of cathepsin B and L. Banati RB; Rothe G; Valet G; Kreutzberg GW Glia; 1993 Feb; 7(2):183-91. PubMed ID: 8432559 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of bovine cathepsins L and S by stefins and cystatins. Leonardi A; Turk B; Turk V Biol Chem Hoppe Seyler; 1996 May; 377(5):319-21. PubMed ID: 8828823 [TBL] [Abstract][Full Text] [Related]
33. Lysosomal thiol cathepsins and their endogenous inhibitors. Distribution and localization. Katunuma N; Kominami E Prog Clin Biol Res; 1985; 180():71-9. PubMed ID: 3898124 [No Abstract] [Full Text] [Related]
34. 3-hydroxy-3-methylglutaryl coenzyme A reductase is sterol-dependently cleaved by cathepsin L-type cysteine protease in the isolated endoplasmic reticulum. Moriyama T; Wada M; Urade R; Kito M; Katunuma N; Ogawa T; Simoni RD Arch Biochem Biophys; 2001 Feb; 386(2):205-12. PubMed ID: 11368343 [TBL] [Abstract][Full Text] [Related]
35. Changes of proteasomes and cathepsins activities and their expression during differentiation of C2C12 myoblasts. Ebisui C; Tsujinaka T; Morimoto T; Fujita J; Ogawa A; Ishidoh K; Kominami E; Tanaka K; Monden M J Biochem; 1995 May; 117(5):1088-94. PubMed ID: 8586624 [TBL] [Abstract][Full Text] [Related]
36. Temperature-dependent enhancement of proteolysis in C2C12 myotubes in association with the activation of 26S proteasome. Morita S; Tsujinaka T; Yano M; Ebisui C; Morimoto T; Fujita J; Ogawa A; Taniguchi M; Shiozaki H; Monden M Biochem Biophys Res Commun; 1996 Nov; 228(3):813-8. PubMed ID: 8941359 [TBL] [Abstract][Full Text] [Related]
37. Effect of cysteine protease inhibitor Ep-475 on TNF-alpha-independent cyclophosphamide-induced apoptosis in mouse lymphosarcoma LS cells. Zhanaeva SY; Korolenko TA; Khoshchenko OM; Spiridonov VK; Nikolin VP; Kaledin VI Bull Exp Biol Med; 2005 Feb; 139(2):186-9. PubMed ID: 16027802 [TBL] [Abstract][Full Text] [Related]
39. Study of the functional share of lysosomal cathepsins by the development of specific inhibitors. Katunuma N; Matsui A; Kakegawa T; Murata E; Asao T; Ohba Y Adv Enzyme Regul; 1999; 39():247-60. PubMed ID: 10470376 [TBL] [Abstract][Full Text] [Related]
40. Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors. Leto G; Pizzolanti G; Tumminello FM; Gebbia N In Vivo; 1994; 8(2):231-6. PubMed ID: 7919127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]